Evaluation of Recurrent Takotsubo Syndrome.
Paul Marano, Jenna Maughan, Okezi Obrutu...
https://pubmed.ncbi.nlm.nih.gov/39324115/Actively Recruiting
Led by Cedars-Sinai Medical Center · Updated on 2026-08-19
1000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting the Cedars-Sinai Smidt Heart Institute Takotsubo Registry and Proteomic Study to collect detailed data from individuals diagnosed with Takotsubo Cardiomyopathy. This observational registry gathers demographic, clinical, hemodynamic, laboratory, therapy, and outcome information to help identify different Takotsubo types, improve diagnosis, predict recurrences, and develop targeted treatments. The study is sponsored by Cedars-Sinai Medical Center and uses patient-driven outreach including social media and online platforms. Participants provide clinical materials like hospitalization records, lab data with troponin levels, ECG, and CTA scans through a secure online system. They also have the option to participate in the proteomic part of the study by sending blood samples collected at home using a Mitra kit. Annual update surveys collect ongoing health status information. The registry aims to build a large U.S.-based database and establish a platform for future patient-centered clinical trials to enhance care and outcomes. Throughout the study, participants upload medical records and complete yearly surveys to help researchers track Takotsubo prevalence, recurrence, and risk factors over up to 30 years. Data is reviewed by trained physicians for accuracy. This long-term follow-up allows monitoring of patients health status after their Takotsubo event, supporting efforts to better understand and manage this condition over time.
CONDITIONS
The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
T
TS Registry
B
BS WHC, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cedars-Sinai Medical Center
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (online)
Duration - Ongoing throughout the study
Participants upload medical records and clinical data related to their Takotsubo diagnosis through a secure online system.
Annual update surveys
Duration - As agreed during participation
Participants may provide blood samples at home using a Mitra kit to contribute to the proteomic study.
Remote sample collection
Duration - Up to 30 years
Researchers track participants' health status and Takotsubo recurrence using annual surveys and data review for up to 30 years.
Annual surveys
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Paul Marano, Jenna Maughan, Okezi Obrutu...
https://pubmed.ncbi.nlm.nih.gov/39324115/Cedars-Sinai Medical Center
Lead Sponsor